Duobrii in Combination With Biologics

Recruiting now · Phase 4

Conditions studied: Psoriasis

In brief

12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks

Key facts

Study ID

NCT04119102

Run by

Psoriasis Treatment Center of Central New Jersey

People needed

25

Starts

2019-10-14

Expected to finish

2020-09-01

Last updated by the study team

2020-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female adult ≥ 18 years of age;
• Diagnosis of chronic plaque-type
• Psoriasis affecting 2%-10% BSA
• Patient is being treated with biologic therapy for a minimum of 24 weeks
• Able and willing to give written informed consent prior to performance of any study-related procedures

You may not qualify if…

• Psoriasis affecting ˂2% or >10% BSA
• Patient not receiving a biologic agent, or receiving biologic agent <24weeks
• Received treatment with any topical antipsoriatic drug product within 14 days prior to the Baseline visit.
• Has previously used DUOBRII

Where it is running

• Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.